Zions Bancorporation’s Oak Street Health, Inc. OSH Stock Holding History

Zions Bancorporation’s Portfolio OSH Stock Details OSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-418	Closed	-$11K	–	1180
2022 Q1	$11K	Buy	+418	New	+$8.81K	﹤0.01%	812

Other funds holding OSH

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Newlight Partners New York $3.9M AUM 96.05% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ROIC

Route One Investment Company San Francisco, California $2.35B AUM 11.7% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Zions Bancorporation's OSH Position: Q2 2022 in Review

Zions Bancorporation sold out of Oak Street Health, Inc. (OSH) in Q2 2022, closing a stake of 418 shares — an estimated $11K sold.

Zions Bancorporation first reported a position in OSH in Q1 2022 and held it in 1 quarter. The position peaked at $11K in Q1 2022. 193 funds tracked by Wall St. Rank hold OSH as of Q2 2022.

Zions Bancorporation reported no remaining Oak Street Health, Inc. position as of Q2 2022 after selling out during the quarter.
Zions Bancorporation sold 418 Oak Street Health, Inc. shares in Q2 2022, an estimated $11K.
Zions Bancorporation first reported a position in Oak Street Health, Inc. in Q1 2022 and held it in 1 quarter.
Zions Bancorporation's Oak Street Health, Inc. position peaked at $11K in Q1 2022.
193 funds tracked by Wall St. Rank held Oak Street Health, Inc. as of Q2 2022.

Based on Zions Bancorporation's 13F filing for Q2 2022, filed 5 Aug 2022.